Recently, various executives have taken part in insider selling activity for the stocks of Tesla Motors Inc (NASDAQ:TSLA), Skyworks Solutions Inc (NASDAQ:SWKS), Novavax, Inc. (NASDAQ:NVAX), Avago Technologies Ltd (NASDAQ:AVGO), and Juno Therapeutics Inc (NASDAQ:JUNO).

Tesla Motors Inc

CFO Deepak Ahuja unloaded 5,000 Tesla Motors shares (40.75% of total stake), valued at $1,288,034, in multiple transactions dated August 18. The shares were sold via automatic sale program. Ahuja now holds 7,270 of the company’s shares that are valued at $1,715,720. According to TipRanks.com, which measures corporate insiders’ success based on their transactions, Deepak Ahuja has an average return of 30.5% and a 100% success rate. Ahuja is ranked #4169 out of 33597 corporate insiders.

Click Here to see the performance of Tesla insiders.

Skyworks Solutions Inc

Chairman and CEO David Aldrich unloaded 1,516 Skyworks Solutions shares, valued at $136,940, on August 18. The shares were sold via automatic sale program. Aldrich now holds 150,091 of the company’s shares that are valued at $13,557,692.

Click Here to see the performance of Skyworks Solutions insiders.

Novavax, Inc.

SVP of Research and Development Gregory Glenn dumped 15,000 Novavax shares, valued at $202,650, in a transaction dated August 18. Glenn now holds 1,158 of the company’s shares that are valued at $15,645. According to TipRanks, Gregory Glenn has an average return of 3.5% and a 66.7% success rate. Glenn is ranked #8875 out of 33597 corporate insiders.

Click Here to see the performance of Novavax insiders.

Avago Technologies Ltd

CFO Anthony Maslowski disposed of 5,000 Avago Technologies shares, valued at $607,900, on August 18. The shares were sold via automatic sale program. Maslowski now holds 77,567 of the company’s shares that are valued at $9,430,595.

Click Here to see the performance of Avago Technologies insiders.

Juno Therapeutics Inc

General Counsel and Secretary Bernard Cassidy unloaded 11,850 Juno Therapeutics shares, valued at $475,677, in two transactions dated August 19. The shares were sold via automatic sale program. Cassidy now holds 116,319 of the company’s shares that are valued at $4,699,221.

Click Here to see the performance of Juno Therapeutics insiders.